TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Study Number: TP-CA-007
Study Summary:
This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Status: Suspended
Enrolling Cohort(s): Stage III-IV EGFR mutated NSCLC
Study Coordinator(s)
- Trupti, 309-243-3662, thattiangadi@illinoiscancercare.com
